A detailed history of Archer Investment Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Archer Investment Corp holds 600 shares of IONS stock, worth $20,604. This represents 0.01% of its overall portfolio holdings.

Number of Shares
600
Previous 600 -0.0%
Holding current value
$20,604
Previous $28.6 Million 15.95%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$36.45 - $47.7 $9,112 - $11,925
-250 Reduced 29.41%
600 $28.6 Million
Q4 2021

Feb 09, 2022

SELL
$25.61 - $35.1 $1,715 - $2,351
-67 Reduced 7.31%
850 $25.9 Million
Q3 2021

Oct 29, 2021

BUY
$33.54 - $40.55 $30,756 - $37,184
917 New
917 $30.8 Million
Q2 2021

Aug 05, 2021

SELL
$34.54 - $47.25 $31,673 - $43,328
-917 Closed
0 $0
Q3 2019

Apr 01, 2020

BUY
$59.06 - $72.15 $48,252 - $58,946
817 Added 817.0%
917 $55,000
Q4 2018

Apr 06, 2020

BUY
$43.37 - $59.54 $4,337 - $5,954
100 New
100 $5,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.87B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Archer Investment Corp Portfolio

Follow Archer Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Archer Investment Corp with notifications on news.